FDA Recalls Desloratadine Tablets Due to Manufacturing Defect
Lupin Pharmaceuticals is recalling Desloratadine 5mg tablets distributed nationwide because N-Nitroso impurity levels exceeded acceptable limits. Affected lots expire in January 2024.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II classification with a manufacturing defect involving chemical impurities exceeding acceptable intake limits. Per the severity rubric, risk-of-harm products without reported injuries receive a High (3) score.
Plain-English summary
Lupin Pharmaceuticals is recalling specific lots of Desloratadine 5mg tablets because manufacturing testing found that N-Nitroso Desloratadine impurity levels exceeded acceptable intake limits. The affected product consists of 100-count and 500-count bottles that were distributed nationwide.
The affected lots are G201822, G201823, and G201824, which expire in January 2024. Consumers with this medication should not use it and should contact their pharmacy or healthcare provider about obtaining a replacement.
The recalled product
- Product
- DESLORATADINE (DESLORATADINE)
- Brand
- DESLORATADINE
- Manufacturer
- Lupin Pharmaceuticals Inc.
- Category
- Drug — Antihistamine
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot # G201822
- exp. date Jan 2024
- 100 count G201823
- 100 count G201824
- 500 count
UPCs (1)
- 0368180153023
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Lupin Pharmaceuticals Inc.
See all →- ModerateLupin Recalls Clobetasol Propionate Cream for Content Uniformity Failures
FDA (Drugs) · 2026-09-02
- SevereGlucagon Emergency Kit Recalled for Manufacturing Process Deviation
FDA (Drugs) · 2026-07-08
- HighPrednisolone Acetate Ophthalmic Suspension Recalled for Foreign Substance
FDA (Drugs) · 2026-07-08
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- ModerateSertraline tablets recalled because bottle seals are not adhering
FDA (Drugs) · 2025-12-17
Same hazard · manufacturing defect
See all →- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-09-02
- HighSun Pharmaceutical Recalls Carbamazepine Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2026-08-26
- HighKnee Prosthesis Trial Recall for Manufacturing Defect
FDA (Devices) · 2026-08-12
- HighU2 Total Knee System Femoral Valgus Adaptor Recall
FDA (Devices) · 2026-08-12
- HighUSTAR II Knee System Hinge Box Trial Recall
FDA (Devices) · 2026-08-12